Collectively, these findings support the therapeutic potential of C. amuricus as a targeted agent for hepatocellular carcinoma (HCC) via modulation of the PI3K/AKT/mTOR signaling axis. This evidence concerns the gene MTOR and hepatocellular carcinoma.